Folic acid supplementation during early hepatocarcinogenesis: cellular and molecular effects


Autoria(s): CHAGAS, Carlos Eduardo Andrade; BASSOLI, Bruna Kempfer; SOUZA, Camila Alexandre Soares de; DEMINICE, Rafael; JORDAO JUNIOR, Alceu Afonso; PAIVA, Sergio Alberto Rupp; DAGLI, Maria Lucia Zaidan; ONG, Thomas Prates; MORENO, Fernando Salvador
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2011

Resumo

Folic acid (FA) supplementation during carcinogenesis is controversial. Considering the impact of liver cancer as a public health problem and mandatory FA fortification in several countries, the role of FA supplementation in hepatocarcinogenesis should be elucidated. We evaluated FA supplementation during early hepatocarcinogenesis. Rats received daily 0.08 mg (FA8 group) or 0.16 mg (FA16 group) of FA/100 g body weight or water (CO group, controls). After a 2-week treatment, animals were subjected to the ""resistant hepatocyte"" model of hepatocarcinogenesis (initiation with diethylnitrosamine, selection/promotion with 2-acetylaminofluorene and partial hepatectomy) and euthanized after 8 weeks of treatment. Compared to the CO group, the FA16 group presented: reduced (p < 0.05) number of persistent and increased (p < 0.05) number of remodeling glutathione S-transferase (GST-P) positive preneoplastic lesions (PNL); reduced (p < 0.05) cell proliferation in persistent GST-P positive PNL; decreased (p < 0.05) hepatic DNA damage; and a tendency (p < 0.10) for decreased c-myc expression in microdissected PNL. Regarding all these parameters, no differences (p > 0.05) were observed between CO and FA8 groups. FA-treated groups presented increased hepatic levels of S-adenosylmethionine but only FA16 group presented increased S-adenosylmethionine/S-adenosylhomocysteine ratio. No differences (p > 0.05) were observed between experimental groups regarding apoptosis in persistent and remodeling GST-P positive PNL, and global DNA methylation pattern in microdissected PNL. Altogether, the FA16 group, but not the FA8 group, presented chemopreventive activity. Reversion of PNL phenotype and inhibition of DNA damage and of c-myc expression represent relevant FA cellular and molecular effects.

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)[2006/60726-1]

Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)

Identificador

INTERNATIONAL JOURNAL OF CANCER, v.129, n.9, p.2073-2082, 2011

0020-7136

http://producao.usp.br/handle/BDPI/23927

10.1002/ijc.25886

http://dx.doi.org/10.1002/ijc.25886

Idioma(s)

eng

Publicador

WILEY-BLACKWELL

Relação

International Journal of Cancer

Direitos

restrictedAccess

Copyright WILEY-BLACKWELL

Palavras-Chave #folic acid supplementation #hepatocarcinogenesis #chemoprevention #preneoplastic lesions #RAT-LIVER CARCINOGENESIS #ADENOSYL-L-METHIONINE #NF-KAPPA-B #C-MYC #HEPATOCELLULAR-CARCINOMA #S-ADENOSYLMETHIONINE #DIETARY-FOLATE #ALTERED FOCI #CANCER #EXPRESSION #Oncology
Tipo

article

original article

publishedVersion